Ngm Biopharmaceuticals Stock Filter Stocks by Fundamentals
NGM Biopharmaceuticals fundamentals help investors to digest information that contributes to NGM Biopharmaceutica's financial success or failures. It also enables traders to predict the movement of NGM Stock. The fundamental analysis module provides a way to measure NGM Biopharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NGM Biopharmaceutica stock.
NGM |
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
All Next | Launch Module |
NGM Fundamentals
Return On Equity | -0.7 | |||
Return On Asset | -0.38 | |||
Operating Margin | (179.78) % | |||
Current Valuation | (36.13 M) | |||
Shares Outstanding | 83.46 M | |||
Shares Owned By Insiders | 21.08 % | |||
Shares Owned By Institutions | 54.16 % | |||
Number Of Shares Shorted | 1.68 M | |||
Price To Earning | (21.12) X | |||
Price To Book | 0.86 X | |||
Price To Sales | 29.10 X | |||
Revenue | 4.42 M | |||
Gross Profit | (125.73 M) | |||
EBITDA | (144.33 M) | |||
Net Income | (142.38 M) | |||
Cash And Equivalents | 297.81 M | |||
Cash Per Share | 3.71 X | |||
Total Debt | 5.38 M | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 7.49 X | |||
Book Value Per Share | 1.79 X | |||
Cash Flow From Operations | (132.2 M) | |||
Short Ratio | 1.26 X | |||
Earnings Per Share | (1.73) X | |||
Target Price | 1.66 | |||
Number Of Employees | 138 | |||
Beta | 1.26 | |||
Market Capitalization | 128.53 M | |||
Total Asset | 168.87 M | |||
Retained Earnings | (724.01 M) | |||
Working Capital | 136.36 M | |||
Current Asset | 330.81 M | |||
Current Liabilities | 43.69 M | |||
Net Asset | 168.87 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in NGM Stock
If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |